Five researchers at the Department of Energy’s Oak Ridge National Laboratory have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
Scientists at ORNL used neutron scattering and supercomputing to better understand how an organic solvent and water work together to break down plant biomass, creating a pathway to significantly improve the production of renewable
Oak Ridge National Laboratory researchers have built a novel microscope that provides a “chemical lens” for viewing biological systems including cell membranes and biofilms.
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
Scientists from the Department of Energy’s Oak Ridge National Laboratory and a dozen other international research institutions have produced the most elaborate set of projections to date that illustrates possible futures for major monsoon regions.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
ORNL welcomed six technology innovators to join the fourth cohort of Innovation Crossroads, the Southeast’s only entrepreneurial research and development program based at a U.S. Department of Energy national laboratory.
A team led by the Department of Energy’s Oak Ridge National Laboratory synthesized a tiny structure with high surface area and discovered how its unique architecture drives ions across interfaces to transport energy or information.
Matthew R. Ryder, a researcher at the Department of Energy’s Oak Ridge National Laboratory, has been named the 2020 Foresight Fellow in Molecular-Scale Engineering.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.